SIMONELLI, Matteo
SIMONELLI, Matteo
Dipartimento Scienze Biomediche
A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis
2013-01-01 Santoro, A; Simonelli, M; Rodriguez-Lope, C; Zucali, P; Camacho, Lh; Granito, A; Senzer, N; Rimassa, L; Abbadessa, G; Schwartz, B; Lamar, M; Savage, Re; Bruix, J
Addition of temozolomide to radiotherapy for treatment of newly diagnosed anaplastic gliomas
2009-01-01 Simonelli, M; Banna, G; Navarria, P; Di Ieva, A; Zucali, P; De Vincenzo, F; Gaetani, P; Condorelli, R; Baena, Rry; Scorsetti, M; Santoro, A
Administration of temozolomide during and after radiotherapy for newly diagnosed high-grade gliomas excluding glioblastoma multiforme
2007-01-01 Banna, Gl; Bettio, D; Scorsetti, M; Navarria, P; Simonelli, M; Baena Riccardo, R; Aimar, E; Gaetani, P; Colombo, Pg; Rognone, F; Santoro, A
Advances in the biology of malignant pleural mesothelioma
2011-01-01 Zucali, Pa; Ceresoli, Gl; De Vincenzo, F; Simonelli, M; Lorenzi, E; Gianoncelli, L; Santoro, A
An Overview of Intracranial Ependymomas in Adults
2021-01-01 Lombardi, Giuseppe; Della Puppa, Alessandro; Pizzi, Marco; Cerretti, Giulia; Bonaudo, Camilla; Gardiman, Marina Paola; Dipasquale, Angelo; Gregucci, Fabiana; Esposito, Alice; De Bartolo, Debora; Zagonel, Vittorina; Simonelli, Matteo; Fiorentino, Alba; Ducray, Francois
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study
2017-01-01 Navarria, P; Pessina, F; Tomatis, S; Soffietti, R; Grimaldi, M; Lopci, E; Chiti, A; Leonetti, A; Casarotti, A; Rossi, M; Cozzi, L; Ascolese, Am; Simonelli, M; Marcheselli, S; Santoro, A; Clerici, E; Bello, L; Scorsetti, M
Association of Supratotal Resection with Progression-Free Survival, Malignant Transformation, and Overall Survival in Lower-Grade Gliomas
2021-01-01 Rossi, Marco; Gay, Lorenzo; Ambrogi, Federico; Nibali, Marco Conti; Sciortino, Tommaso; Puglisi, Guglielmo; Leonetti, Antonella; Mocellini, Cristina; Caroli, Manuela; Cordera, Susanna; Simonelli, Matteo; Pessina, Federico; Navarria, Piera; Pace, Andrea; Soffietti, Riccardo; Rudà, Roberta; Riva, Marco; Bello, Lorenzo
Brain metastases and next-generation anticancer therapies: a survival guide for clinicians
2024-01-01 Dipasquale, Angelo; Barigazzi, Chiara; Losurdo, Agnese; Persico, Pasquale; Di Muzio, Antonio; Navarria, Piera; Pessina, Federico; van den Bent, Martin; Santoro, Armando; Simonelli, Matteo
Carbon-11-methionine PET-CT as an imaging biomarker in brain gliomas eligible for surgery
2014-01-01 Lopci, E; Bello, L; Olivari, L; Raneri, F; Simonelli, M; Riva, M; Navarria, P; Zucali, Pa; Colombo, P; Scorsetti, M; Santoro, A; Chiti, A
Cerebrospinal fluid tumor DNA for liquid biopsy in glioma patients’ management: close to clinic
2020-01-01 Simonelli, M; Dipasquale, A; Orzan, F; Lorenzi, E; Persico, P; Navarria, P; Pessina, F; Conti Nibali, M; Bello, L; Santoro, A; Boccaccio, C
Changes in shedding of soluble tumor necrosis factor receptors (sR1/R2) and in dynamic MRI as early predictors of outcome with NGR-hTNF
2013-01-01 Zucali, Pa; Simonelli, M; De Vincenzo, F; Santoro, A; Lambiase, A; Bordignon, C
Checkpoint Inhibitors as High-Grade Gliomas Treatment: State of the Art and Future Perspectives
2021-01-01 Persico, Pasquale; Lorenzi, Elena; Dipasquale, Angelo; Pessina, Federico; Navarria, Pierina; Politi, Letterio S.; Santoro, Armando; Simonelli, Matteo
Checkpoint inhibitors as treatment for malignant gliomas: "A long way to the top"
2018-01-01 Simonelli, M; Persico, P; Perrino, M; Zucali, P; Navarria, P; Pessina, F; Scorsetti, M; Bello, L; Santoro, A
Conducting Phase I Trials During the SARS-Coronavirus-2 Outbreak: About Science and Care
2020-01-01 Dipasquale, Angelo; Persico, Pasquale; Lorenzi, Elena; Bertossi, Monica; Santoro, Armando; Simonelli, Matteo
Correlation of microvascular fractal dimension with positron emission tomography [C-11]-methionine uptake in glioblastoma multiforme: Preliminary findings
2010-01-01 Di Ieva, A; Grizzi, F; Tschabitscher, M; Colombo, P; Casali, M; Simonelli, M; Widhalm, G; Muzzio, Pc; Matula, C; Chiti, A; Baena, Rry
COVID-19 and liver cancer clinical trials: not everything is lost
2020-01-01 D'Alessio, A; Personeni, N; Pressiani, T; Bozzarelli, S; Smiroldo, V; Simonelli, M; Lleo, A; Santoro, A; Rimassa, L
COVID-19 lung injury as a primer for immune checkpoint inhibitors (ICIs)-related pneumonia in a patient affected by squamous head and neck carcinoma treated with PD-L1 blockade: a case report
2021-01-01 Dipasquale, Angelo; Persico, Pasquale; Lorenzi, Elena; Rahal, Daoud; Santoro, Armando; Simonelli, Matteo
Definition of the Prognostic Role of MGMT Promoter Methylation Value by Pyrosequencing in Newly Diagnosed IDH Wild-Type Glioblastoma Patients Treated with Radiochemotherapy: A Large Multicenter Study
2022-01-01 Caccese, Mario; Simonelli, Matteo; Villani, Veronica; Rizzato, Simona; Ius, Tamara; Pasqualetti, Francesco; Russo, Marco; Rudà, Roberta; Amoroso, Rosina; Bellu, Luisa; Bertorelle, Roberta; Cavallin, Francesco; Dipasquale, Angelo; Carosi, Mariantonia; Pizzolitto, Stefano; Cesselli, Daniela; Persico, Pasquale; Casini, Beatrice; Fassan, Matteo; Zagonel, Vittorina; Lombardi, Giuseppe
Depatuxizumab Mafodotin (Depatux-M) Plus Temozolomide in Recurrent Glioblastoma Patients: Real-World Experience from a Multicenter Study of Italian Association of Neuro-Oncology (AINO)
2021-01-01 Padovan, Marta; Eoli, Marica; Pellerino, Alessia; Rizzato, Simona; Caserta, Claudia; Simonelli, Matteo; Michiara, Maria; Caccese, Mario; Anghileri, Elena; Cerretti, Giulia; Rudà, Roberta; Zagonel, Vittorina; Lombardi, Giuseppe
Editorial for "Noninvasive Assessment of MGMT Promoter Methylation Status in World Health Organization Grade II-IV Glioma Using Histogram Analysis of Inflow-Based Vascular-Space Occupancy Combined with Structural MR Imaging"
2021-01-01 Politi, Letterio S; Pessina, Federico; Simonelli, Matteo; Navarria, Pierina
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis | 1-gen-2013 | Santoro, A; Simonelli, M; Rodriguez-Lope, C; Zucali, P; Camacho, Lh; Granito, A; Senzer, N; Rimassa, L; Abbadessa, G; Schwartz, B; Lamar, M; Savage, Re; Bruix, J | |
| Addition of temozolomide to radiotherapy for treatment of newly diagnosed anaplastic gliomas | 1-gen-2009 | Simonelli, M; Banna, G; Navarria, P; Di Ieva, A; Zucali, P; De Vincenzo, F; Gaetani, P; Condorelli, R; Baena, Rry; Scorsetti, M; Santoro, A | |
| Administration of temozolomide during and after radiotherapy for newly diagnosed high-grade gliomas excluding glioblastoma multiforme | 1-gen-2007 | Banna, Gl; Bettio, D; Scorsetti, M; Navarria, P; Simonelli, M; Baena Riccardo, R; Aimar, E; Gaetani, P; Colombo, Pg; Rognone, F; Santoro, A | |
| Advances in the biology of malignant pleural mesothelioma | 1-gen-2011 | Zucali, Pa; Ceresoli, Gl; De Vincenzo, F; Simonelli, M; Lorenzi, E; Gianoncelli, L; Santoro, A | |
| An Overview of Intracranial Ependymomas in Adults | 1-gen-2021 | Lombardi, Giuseppe; Della Puppa, Alessandro; Pizzi, Marco; Cerretti, Giulia; Bonaudo, Camilla; Gardiman, Marina Paola; Dipasquale, Angelo; Gregucci, Fabiana; Esposito, Alice; De Bartolo, Debora; Zagonel, Vittorina; Simonelli, Matteo; Fiorentino, Alba; Ducray, Francois | |
| Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study | 1-gen-2017 | Navarria, P; Pessina, F; Tomatis, S; Soffietti, R; Grimaldi, M; Lopci, E; Chiti, A; Leonetti, A; Casarotti, A; Rossi, M; Cozzi, L; Ascolese, Am; Simonelli, M; Marcheselli, S; Santoro, A; Clerici, E; Bello, L; Scorsetti, M | |
| Association of Supratotal Resection with Progression-Free Survival, Malignant Transformation, and Overall Survival in Lower-Grade Gliomas | 1-gen-2021 | Rossi, Marco; Gay, Lorenzo; Ambrogi, Federico; Nibali, Marco Conti; Sciortino, Tommaso; Puglisi, Guglielmo; Leonetti, Antonella; Mocellini, Cristina; Caroli, Manuela; Cordera, Susanna; Simonelli, Matteo; Pessina, Federico; Navarria, Piera; Pace, Andrea; Soffietti, Riccardo; Rudà, Roberta; Riva, Marco; Bello, Lorenzo | |
| Brain metastases and next-generation anticancer therapies: a survival guide for clinicians | 1-gen-2024 | Dipasquale, Angelo; Barigazzi, Chiara; Losurdo, Agnese; Persico, Pasquale; Di Muzio, Antonio; Navarria, Piera; Pessina, Federico; van den Bent, Martin; Santoro, Armando; Simonelli, Matteo | |
| Carbon-11-methionine PET-CT as an imaging biomarker in brain gliomas eligible for surgery | 1-gen-2014 | Lopci, E; Bello, L; Olivari, L; Raneri, F; Simonelli, M; Riva, M; Navarria, P; Zucali, Pa; Colombo, P; Scorsetti, M; Santoro, A; Chiti, A | |
| Cerebrospinal fluid tumor DNA for liquid biopsy in glioma patients’ management: close to clinic | 1-gen-2020 | Simonelli, M; Dipasquale, A; Orzan, F; Lorenzi, E; Persico, P; Navarria, P; Pessina, F; Conti Nibali, M; Bello, L; Santoro, A; Boccaccio, C | |
| Changes in shedding of soluble tumor necrosis factor receptors (sR1/R2) and in dynamic MRI as early predictors of outcome with NGR-hTNF | 1-gen-2013 | Zucali, Pa; Simonelli, M; De Vincenzo, F; Santoro, A; Lambiase, A; Bordignon, C | |
| Checkpoint Inhibitors as High-Grade Gliomas Treatment: State of the Art and Future Perspectives | 1-gen-2021 | Persico, Pasquale; Lorenzi, Elena; Dipasquale, Angelo; Pessina, Federico; Navarria, Pierina; Politi, Letterio S.; Santoro, Armando; Simonelli, Matteo | |
| Checkpoint inhibitors as treatment for malignant gliomas: "A long way to the top" | 1-gen-2018 | Simonelli, M; Persico, P; Perrino, M; Zucali, P; Navarria, P; Pessina, F; Scorsetti, M; Bello, L; Santoro, A | |
| Conducting Phase I Trials During the SARS-Coronavirus-2 Outbreak: About Science and Care | 1-gen-2020 | Dipasquale, Angelo; Persico, Pasquale; Lorenzi, Elena; Bertossi, Monica; Santoro, Armando; Simonelli, Matteo | |
| Correlation of microvascular fractal dimension with positron emission tomography [C-11]-methionine uptake in glioblastoma multiforme: Preliminary findings | 1-gen-2010 | Di Ieva, A; Grizzi, F; Tschabitscher, M; Colombo, P; Casali, M; Simonelli, M; Widhalm, G; Muzzio, Pc; Matula, C; Chiti, A; Baena, Rry | |
| COVID-19 and liver cancer clinical trials: not everything is lost | 1-gen-2020 | D'Alessio, A; Personeni, N; Pressiani, T; Bozzarelli, S; Smiroldo, V; Simonelli, M; Lleo, A; Santoro, A; Rimassa, L | |
| COVID-19 lung injury as a primer for immune checkpoint inhibitors (ICIs)-related pneumonia in a patient affected by squamous head and neck carcinoma treated with PD-L1 blockade: a case report | 1-gen-2021 | Dipasquale, Angelo; Persico, Pasquale; Lorenzi, Elena; Rahal, Daoud; Santoro, Armando; Simonelli, Matteo | |
| Definition of the Prognostic Role of MGMT Promoter Methylation Value by Pyrosequencing in Newly Diagnosed IDH Wild-Type Glioblastoma Patients Treated with Radiochemotherapy: A Large Multicenter Study | 1-gen-2022 | Caccese, Mario; Simonelli, Matteo; Villani, Veronica; Rizzato, Simona; Ius, Tamara; Pasqualetti, Francesco; Russo, Marco; Rudà, Roberta; Amoroso, Rosina; Bellu, Luisa; Bertorelle, Roberta; Cavallin, Francesco; Dipasquale, Angelo; Carosi, Mariantonia; Pizzolitto, Stefano; Cesselli, Daniela; Persico, Pasquale; Casini, Beatrice; Fassan, Matteo; Zagonel, Vittorina; Lombardi, Giuseppe | |
| Depatuxizumab Mafodotin (Depatux-M) Plus Temozolomide in Recurrent Glioblastoma Patients: Real-World Experience from a Multicenter Study of Italian Association of Neuro-Oncology (AINO) | 1-gen-2021 | Padovan, Marta; Eoli, Marica; Pellerino, Alessia; Rizzato, Simona; Caserta, Claudia; Simonelli, Matteo; Michiara, Maria; Caccese, Mario; Anghileri, Elena; Cerretti, Giulia; Rudà, Roberta; Zagonel, Vittorina; Lombardi, Giuseppe | |
| Editorial for "Noninvasive Assessment of MGMT Promoter Methylation Status in World Health Organization Grade II-IV Glioma Using Histogram Analysis of Inflow-Based Vascular-Space Occupancy Combined with Structural MR Imaging" | 1-gen-2021 | Politi, Letterio S; Pessina, Federico; Simonelli, Matteo; Navarria, Pierina |